Double Expressor Lymphoma

specific

A diffuse large B-cell lymphoma characterized by double expression of MYC and BCL2 proteins without MYC and BCL2 gene aberrations. These lymphomas may have a worse prognosis than other diffuse large B-cell lymphomas, not otherwise specified, but they are not as aggressive as the high-grade B-cell lymphomas, with rearrangements of MYC and BCL2 and/or BCL6 genes.

48

Centers

48

Active Trials

Cancer Funding

Top Centers for Double Expressor Lymphoma(48)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.0
2
NCI Comprehensive
Active Research Program
51.0
3
NCI Comprehensive
Active Research Program
51.0
4
NCI Comprehensive
Active Research Program
51.0
5
NCI Comprehensive
Active Research Program
51.0
6
NCI Comprehensive
Active Research Program
51.0
7
NCI Comprehensive
Active Research Program
51.0
8
NCI Comprehensive
Active Research Program
51.0
9
NCI Comprehensive
Active Research Program
51.0
10
NCI Comprehensive
Active Research Program
51.0
1151.0
12
NCI Comprehensive
Active Research Program
51.0
13
NCI Comprehensive
Active Research Program
51.0
14
NCI Comprehensive
Active Research Program
51.0
15
NCI Comprehensive
Active Research Program
51.0
16
NCI Comprehensive
Active Research Program
51.0
17
NCI Comprehensive
Active Research Program
51.0
18
NCI Comprehensive
Active Research Program
51.0
19
NCI Clinical
Active Research Program
51.0
20
NCI Comprehensive
Active Research Program
51.0
21
NCI Comprehensive
Active Research Program
51.0
22
Active Research Program
51.0
23
NCI Comprehensive
Active Research Program
51.0
24
Active Research Program
51.0
25
NCI Comprehensive
Active Research Program
51.0
26
NCI Comprehensive
Active Research Program
51.0
27
NCI Clinical
Active Research Program
51.0
28
NCI Comprehensive
Active Research Program
51.0
29
NCI Comprehensive
Active Research Program
51.0
30
NCI Comprehensive
Active Research Program
51.0
31
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
51.0
32
Active Research Program
51.0
33
NCI Clinical
Active Research Program
51.0
34
NCI Comprehensive
Active Research Program
51.0
35
Active Research Program
51.0
36
Active Research Program
51.0
37
NCI Comprehensive
Active Research Program
51.0
38
Active Research Program
51.0
39
NCI Basic_laboratory
Active Research Program
51.0
40
Active Research Program
51.0
41
Active Research Program
51.0
42
Active Research Program
51.0
43
Active Research Program
51.0
44
Active Research Program
51.0
45
Active Research Program
51.0
46
Active Research Program
51.0
47
Active Research Program
51.0
48
Active Research Program
51.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →